Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis

Phase 1/2 Completed 30 enrolled Anterogen Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of allogeneic adipose-derived stem cells (ALLO-ASC) in patients with lateral epicondylitis.

Timeline

Start: 2014-01
Primary completion: 2014-10
Completion: 2015-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ALLO-ASC-TI	Cell therapy	—	—

Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis

Summary

Timeline

Drugs

Indications